Reference Citation Analysis: Find an Article, Find a Category, Find a Journal, Find a Scholar

For: Pitoia F. Sorafenib: is a partial response and stabilization of disease greater than 70% a modest response? Endocr Relat Cancer 2014;21:L1-L2. [PMID: 24465001 DOI: 10.1530/erc-13-0544] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.1] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 12/16/2022]

For:	Pitoia F. Sorafenib: is a partial response and stabilization of disease greater than 70% a modest response? Endocr Relat Cancer 2014;21:L1-L2. [PMID: 24465001 DOI: 10.1530/erc-13-0544] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.1] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 12/16/2022]

Number	Cited by Other Article(s)
1	Shen CT, Qiu ZL, Luo QY. More effective agents still needed for progressive radioiodine-refractory differentiated thyroid cancer. Endocr Relat Cancer 2014;21:L3-4. [PMID: 24639563 DOI: 10.1530/erc-14-0094] [Citation(s) in RCA: 2] [Impact Index Per Article: 0.2] [Reference Citation Analysis] [MESH Headings] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 11/08/2022] Abstract Collapse Key Words Collapse MESH Headings Antineoplastic Agents/therapeutic use Humans Niacinamide/analogs & derivatives Niacinamide/therapeutic use Phenylurea Compounds/therapeutic use Protein Kinase Inhibitors/therapeutic use Sorafenib Thyroid Neoplasms/drug therapy Collapse Grants Collapse Affiliation(s) Collapse

Number

Cited by Other Article(s)

Shen CT, Qiu ZL, Luo QY. More effective agents still needed for progressive radioiodine-refractory differentiated thyroid cancer. Endocr Relat Cancer 2014;21:L3-4. [PMID: 24639563 DOI: 10.1530/erc-14-0094] [Citation(s) in RCA: 2] [Impact Index Per Article: 0.2] [Reference Citation Analysis] [MESH Headings] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 11/08/2022]